These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3087811)

  • 1. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GnRH-TRH stimulation tests in patients with mastopathy].
    Kasch R; Meissner J; Kunkel S
    Zentralbl Gynakol; 1988; 110(5):298-303. PubMed ID: 3131977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rational hormone diagnosis in normocyclic functional sterility].
    Moltz L; Leidenberger F; Weise C
    Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):756-68. PubMed ID: 1835948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
    Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses.
    Leppäluoto J; Rönnberg L; Ylöstalo P
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP; Boyar AP; Cohen C; Strong LE
    J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K; Stanosz S
    Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
    Dogliotti L; Faggiuolo R; Ferusso A; Orlandi F; Sandrucci S; Tibo A; Angeli A
    Horm Res; 1985; 21(3):137-44. PubMed ID: 3922866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.